☆ 4.7 Article

Site-oriented conjugation of poly(2-methacryloyloxyethyl phosphorylcholine) for enhanced brain delivery of antibody

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Anti-amyloid antibody therapies in Alzheimer's disease

Robert Perneczky et al.

Summary: After years of failed attempts, a breakthrough has been achieved in developing a disease-modifying therapy for Alzheimer's disease with a monoclonal antibody targeting amyloid-beta protofibrils. The positive results of the trial, including slowing disease progression and amyloid-beta reduction, provide consistent evidence of clinical efficacy. The article discusses the reasons for the previous failures, compares safety profiles of different antibodies, and proposes a new model for using blood-based biomarkers to facilitate antibody treatments.

BRAIN (2023)

Add to Collection

Review Pharmacology & Pharmacy

Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases

Xihui Gao et al.

Summary: The blood-brain barrier (BBB) serves as a crucial physiological barrier that restricts the exchange of substances between blood and brain tissues. Peptide decorated nanocarriers have shown promise in overcoming the BBB for diagnosis and therapy of brain diseases. However, challenges related to stability, safety, and immunocompatibility need to be addressed for their clinical translation.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Add to Collection

Review Pharmacology & Pharmacy

IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport

Ruben J. Boado

Summary: The treatment of neurological disorders requires the transport of therapeutic drugs across the blood-brain barrier (BBB). This can be achieved through the use of brain-penetrating bifunctional IgG fusion proteins, which consist of a transport domain and a therapeutic domain. These proteins target specific receptors on the BBB and have been validated in animal models and human clinical trials.

PHARMACEUTICS (2022)

Add to Collection

Article Cell Biology

Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides

Zhanchi Zhu et al.

Summary: The study demonstrates that engineered sEVs can effectively treat glioma by crossing the blood-brain barrier and specifically targeting brain tumors. The high targeting efficiency of these dual-modified sEVs for BBB and glioma was confirmed in vitro and in animal models.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

Add to Collection

Review Pharmacology & Pharmacy

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

Nikhil Pandey et al.

Summary: This review focuses on drug delivery strategies and nanotherapeutic technologies targeting brain-invading cancer cells and highlights the importance of treatments for invasive cells.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Add to Collection

Article Oncology

Alternating Radiation Fractionations Overcome Radioresistance in Patient-Derived Glioblastoma Cells

L. Nassour et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Add to Collection

Article Medicine, Research & Experimental

N-cadherin upregulation mediates adaptive radioresistance in glioblastoma

Satoru Osuka et al.

Summary: Glioblastoma is composed of heterogeneous tumor cell populations, including glioma stem cells (GSCs) with stem cell properties. GSCs, which are less radiation sensitive, drive tumor formation and recurrence. Increase in N-cadherin expression enhances radioresistance and stemness in GSCs, while targeting N-cadherin can reverse the radiation resistance phenotype in these cells.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Virology

Neutralizing Antibody Therapeutics for COVID-19

Aeron C. Hurt et al.

Summary: The emergence of SARS-CoV-2 and the subsequent COVID-19 pandemic have created an urgent need for effective therapeutic strategies. Neutralizing antibodies have shown potential in treating and preventing COVID-19, but their efficacy in severe cases remains varied. Treatment may lead to the formation of antiviral resistant escape mutants, highlighting the importance of exploring strategies to minimize risk.

VIRUSES-BASEL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives

Aida Kouhi et al.

Summary: Monoclonal antibodies have high specificity and are being investigated for drug delivery to the CNS for neurological disease treatment, with the main challenge being the presence of the blood-brain barrier limiting drug uptake into the brain. Current research focuses on improving the physicochemical and biochemical properties of antibodies to enhance their uptake in the brain.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Oncology

Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma

Hamid Maadi et al.

Summary: Overexpression of HER2 receptors is associated with poor clinical outcomes, and trastuzumab has shown promising benefits for HER2-positive tumors, although some patients are unresponsive or develop resistance. Studies on the mechanisms of trastuzumab's action remain controversial.

CANCERS (2021)

Add to Collection

Article Medicine, Research & Experimental

Impact of IgG subclass on molecular properties of monoclonal antibodies

Yu Tang et al.

Summary: In recent decades, IgG-based monoclonal antibodies have become a dominant class of biotherapeutics. Different IgG subclasses have significant effects on molecular properties, with IgG1 antibodies showing higher solubility in a common buffer matrix compared to IgG2 or IgG4 antibodies.

MABS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Site-selective modification strategies in antibody-drug conjugates

Stephen J. Walsh et al.

Summary: ADCs utilize antibodies' targeting ability to deliver cytotoxic payloads to specific cells. Research focuses on the critical nature of the linkage strategy and generation of homogeneous constructs for precise drug loading. Homogeneous ADCs have superior pharmacological profiles compared to heterogeneous counterparts.

CHEMICAL SOCIETY REVIEWS (2021)

Add to Collection

Review Oncology

Antibody therapeutics and immunoregulation in cancer and autoimmune disease

Masahiro Yasunaga

SEMINARS IN CANCER BIOLOGY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier

Hyun Su Min et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Add to Collection

Article Neurosciences

Characterization of novel conformation-selective alpha-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

Michael X. Henderson et al.

NEUROBIOLOGY OF DISEASE (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment

Yan Zou et al.

ADVANCED MATERIALS (2020)

Add to Collection

Article Multidisciplinary Sciences

Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn

John S. Ruano-Salguero et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Rabies virus glycoprotein-amplified hierarchical targeted hybrids capable of magneto-electric penetration delivery to orthotopic brain tumor

Yu-Lin Su et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection

Review Neurosciences

Development of early diagnosis of Parkinson's disease: Illusion or reality?

Michael Ugrumov

CNS NEUROSCIENCE & THERAPEUTICS (2020)

Add to Collection

Review Neurosciences

A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity

Hossam Kadry et al.

FLUIDS AND BARRIERS OF THE CNS (2020)

Add to Collection

Review Cell Biology

Development of therapeutic antibodies for the treatment of diseases

Ruei-Min Lu et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Suppressive effects of 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymer on the adherence of Candida species and MRSA to acrylic denture resin

Natsumi Fujiwara et al.

HELIYON (2020)

Add to Collection

Review Immunology

Monoclonal Antibodies in Cancer Therapy

David Zahavi et al.

ANTIBODIES (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration

Duo Xu et al.

ADVANCED MATERIALS (2019)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Engineered antibodies: new possibilities for brain PET?

Dag Sehlin et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Add to Collection

Article Engineering, Biomedical

Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice

Jing Wen et al.

NATURE BIOMEDICAL ENGINEERING (2019)

Add to Collection

Review Neurosciences

Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges

Victor M. Pulgar

FRONTIERS IN NEUROSCIENCE (2019)

Add to Collection

Article Chemistry, Multidisciplinary

A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System

Di Wu et al.

ADVANCED MATERIALS (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy

Lei Han et al.

ADVANCED MATERIALS (2019)

Add to Collection

Review Instruments & Instrumentation

Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends

Hira Choudhury et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages

Shicheng Su et al.

CELL (2018)

Add to Collection

Article Chemistry, Physical

Phosphorylcholine polymer nanocapsules prolong the circulation time and reduce the immunogenicity of therapeutic proteins

Sheng Liang et al.

NANO RESEARCH (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Engineering disulfide bonds within an antibody

Yoshihisa Hagihara et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)

Add to Collection

Review Medicine, Research & Experimental

Disulfide bond structures of IgG molecules Structural variations, chemical modifications and possible impacts to stability and biological function

Hongcheng Liu et al.

MABS (2012)

Add to Collection

Review Biochemical Research Methods

Antibodies in metabolic diseases

Bianca Ahrens

NEW BIOTECHNOLOGY (2011)

Add to Collection

Article Nanoscience & Nanotechnology

A novel intracellular protein delivery platform based on single-protein nanocapsules

Ming Yan et al.

NATURE NANOTECHNOLOGY (2010)

Add to Collection

Article Biochemical Research Methods

Tricine-SDS-PAGE

Hermann Schaegger

NATURE PROTOCOLS (2006)

Add to Collection

Article Oncology

Biology of HER2 and its importance in breast cancer

Y Yarden

ONCOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.